CLINICAL_TRIALS
trial_result
· 2014-09-17
Clinical Trial Update: Infrared Coagulation in Preventing Anal Cancer in Patients With HIV Who Have Anal Neoplasia [Phase 1]
Summary
This completed Phase 1 study evaluated infrared coagulation as a preventive approach for anal cancer in HIV-positive individuals with anal neoplasia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: AIDS Malignancy Consortium | Conditions: Anal Cancer, Precancerous Condition | Phase 1 | Status: COMPLETED